Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Merkel Cell Carcinoma: New Trends.
Zwijnenburg EM, Lubeek SFK, Werner JEM, Amir AL, Weijs WLJ, Takes RP, Pegge SAH, van Herpen CML, Adema GJ, Kaanders JHAM. Zwijnenburg EM, et al. Among authors: adema gj. Cancers (Basel). 2021 Mar 31;13(7):1614. doi: 10.3390/cancers13071614. Cancers (Basel). 2021. PMID: 33807446 Free PMC article. Review.
Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells.
Van Herpen CM, Huijbens R, Looman M, De Vries J, Marres H, Van De Ven J, Hermsen R, Adema GJ, De Mulder PH. Van Herpen CM, et al. Among authors: adema gj. Clin Cancer Res. 2003 Aug 1;9(8):2950-6. Clin Cancer Res. 2003. PMID: 12912941 Clinical Trial.
Intratumoral administration of recombinant human interleukin 12 in head and neck squamous cell carcinoma patients elicits a T-helper 1 profile in the locoregional lymph nodes.
van Herpen CM, Looman M, Zonneveld M, Scharenborg N, de Wilde PC, van de Locht L, Merkx MA, Adema GJ, de Mulder PH. van Herpen CM, et al. Among authors: adema gj. Clin Cancer Res. 2004 Apr 15;10(8):2626-35. doi: 10.1158/1078-0432.ccr-03-0304. Clin Cancer Res. 2004. PMID: 15102664 Clinical Trial.
Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH. van Herpen CM, et al. Among authors: adema gj. Clin Cancer Res. 2005 Mar 1;11(5):1899-909. doi: 10.1158/1078-0432.CCR-04-1524. Clin Cancer Res. 2005. PMID: 15756016 Clinical Trial.
Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation.
van Herpen CM, van der Voort R, van der Laak JA, Klasen IS, de Graaf AO, van Kempen LC, de Vries IJ, Boer TD, Dolstra H, Torensma R, van Krieken JH, Adema GJ, De Mulder PH. van Herpen CM, et al. Among authors: adema gj. Int J Cancer. 2008 Nov 15;123(10):2354-61. doi: 10.1002/ijc.23756. Int J Cancer. 2008. PMID: 18729197 Free article. Clinical Trial.
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice.
Lesterhuis WJ, Punt CJ, Hato SV, Eleveld-Trancikova D, Jansen BJ, Nierkens S, Schreibelt G, de Boer A, Van Herpen CM, Kaanders JH, van Krieken JH, Adema GJ, Figdor CG, de Vries IJ. Lesterhuis WJ, et al. Among authors: adema gj. J Clin Invest. 2011 Aug;121(8):3100-8. doi: 10.1172/JCI43656. Epub 2011 Jul 18. J Clin Invest. 2011. PMID: 21765211 Free PMC article.
293 results